In This Issue
- A First for Primary CNS Lymphoma: FDA Lifts CAR T-Cell Therapy Exclusion Based on the Results from a Dana-Farber Led Study
- Trial Updates in Follicular and Marginal Zone Lymphoma
- Toward Targeted Treatment Strategies for Mantle Cell Lymphoma
- Updates in Chronic Lymphocytic Leukemia
- Pembrolizumab Plus CAR T-Cell Therapy in Rare B-Cell Lymphomas
- Faculty Spotlight: Christine Ryan
Additional Resources
Division of Lymphoma
Adult Stem Cell Transplant Program
Cellular Therapies Program